Validation of the adult attention-deficit/hyperactivity disorder quality-of-life scale in European patients: comparison with patients from the USA

por Brod, Meryl, Adler, Lenard A., Lipsius, Sarah, Tanaka, Yoko, Heinloth, Alexandra N., Upadhyaya, Himanshu
Publicado 2015

Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

por Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Publicado 2019

Correction to: Galcanezumab in episodic migraine: subgroup analyses of efficacy by high versus low frequency of migraine headaches in phase 3 studies (EVOLVE-1 & EVOLVE-2)

por Silberstein, Stephen D., Stauffer, Virginia L., Day, Katie A., Lipsius, Sarah, Wilson, Maria-Carmen
Publicado 2019

Review of Efficacy and Safety of Duloxetine 40 to 60 mg Once Daily in Patients with Diabetic Peripheral Neuropathic Pain

por Skljarevski, Vladimir, Frakes, Elijah P., Sagman, Doron, Lipsius, Sarah, Heinloth, Alexandra N., Dueñas Tentori, Héctor J.
Publicado 2012

Efficacy of Galcanezumab for Migraine Prevention in Patients With a Medical History of Anxiety and/or Depression: A Post Hoc Analysis of the Phase 3, Randomized, Double‐Blind, Plac...

por Smitherman, Todd A., Tietjen, Gretchen E., Schuh, Kory, Skljarevski, Vladimir, Lipsius, Sarah, D’Souza, Deborah N., Pearlman, Eric M.
Publicado 2020